Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Allied Healthcare Group Ltd Lodges 510 With FDA For Cardiocel Marketing Approval


Monday, 1 Apr 2013 05:26pm EDT 

Allied Healthcare Group Ltd announced that on March 29, US time, the Company lodged its Premarket Notification 510(k) Submission for CardioCel in the United States (U.S). CardioCel is a cardiovascular tissue patch used to repair heart deformities including repairing and reconstructing heart valves. CardioCel has unique properties making it suited for use by surgeons as a regenerative cardiac repair tissue, as well as delivering key benefits to patients compared to existing surgical approaches. 

Company Quote

0.115
0.0050 +4.55%
24 Dec 2014